Stoke Therapeutics, Inc.
EPS
| Fiscal Year | EPS | Cyclically Adjusted EPS |
|---|---|---|
| FY2018 | $-17.65 | $-22.05 |
| FY2019 | $-1.80 | $-12.13 |
| FY2020 | $-1.56 | $-8.72 |
| FY2021 | $-2.34 | $-7.21 |
| FY2022 | $-2.60 | $-6.33 |
| FY2023 | $-2.38 | $-5.68 |
| FY2024 | $-1.65 | $-5.11 |
| FY2025 | $-0.12 | $-4.48 |
EPS
| Fiscal Year | EPS | Cyclically Adjusted EPS |
|---|---|---|
| FY2018 | $-17.65 | $-22.05 |
| FY2019 | $-1.80 | $-12.13 |
| FY2020 | $-1.56 | $-8.72 |
| FY2021 | $-2.34 | $-7.21 |
| FY2022 | $-2.60 | $-6.33 |
| FY2023 | $-2.38 | $-5.68 |
| FY2024 | $-1.65 | $-5.11 |
| FY2025 | $-0.12 | $-4.48 |